Champlain Investment Partners’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-2,422,070
| Closed | -$68.8M | – | 133 |
|
|
2022
Q2 | $68.8M | Sell |
2,422,070
-1,160,460
| -32% | -$33M | 0.44% | 93 |
|
|
2022
Q1 | $126M | Buy |
3,582,530
+28,405
| +0.8% | +$1M | 0.65% | 70 |
|
|
2021
Q4 | $149M | Buy |
3,554,125
+270,304
| +8% | +$11.3M | 0.67% | 64 |
|
|
2021
Q3 | $161M | Sell |
3,283,821
-171,804
| -5% | -$8.43M | 0.77% | 53 |
|
|
2021
Q2 | $144M | Buy |
3,455,625
+1,746,410
| +102% | +$72.9M | 0.69% | 61 |
|
|
2021
Q1 | $60.9M | Buy |
+1,709,215
| New | +$60.9M | 0.32% | 108 |
|